Activity value 75china Buyer&Supplier,Last transaction date:
2025-12-16
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zhejing starry pharmaceutical co.ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 69 transactions, with a transaction quantity of 135474.92 and a transaction weight of 28609.28.
YearTransactionsQuantityWeight
202473169032.1728700.16
202569135474.9228609.28
Bill of lading data
<
1/15
>
Trade date
2025/12/16
B/L No.
107802304850
Suppliers
zhejing starry pharmaceutical co.ltd.
Buyers
công ty cổ phần dược phẩm cpc1 hà nội
POLs
——
PODs
——
Supply area
Other
Purchas area
Vietnam
Weight
——
Amount
300
Hs code
29242990
Product tags
cyclic amides
Product description
Iodixanol: Nguyên liệu dạng bột dùng để nghiên cứu, kiểm nghiệm thuốc. Tiêu chuẩn: In house. Lô: C054-2507102. NSX: 07/2025. HD: 07/2028. Mới 100%
Expand
Trade date
2025/12/11
B/L No.
55301/111225/0161250
Suppliers
zhejing starry pharmaceutical co.ltd.
Buyers
тоо нур май фармация
zhejing starry pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as iohexol usp,iohexol,levofloxacin hemihydrat.
According to the 52wmb.com global trade database, as of 2025-12-16, the company has completed 878 international trades,
with its main trading regions covering india,pakistan,russia etc.
The core products include HS29242990,HS2924299909,HS29349990 etc,
often transported via shanghai,port singapore, port hangzhou etc,
and its main trading partners are j b chemicals pharmaceuticals ltd.,arco lifesciences india pvt.ltd.,unijules life sciences ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejing starry pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.